# Cardiac Arrhythmia Pilot Study (CAPS)

> **NCT00000504** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Arrhythmia
- Cardiovascular Diseases
- Heart Diseases
- Ventricular Arrhythmia

## Interventions

- **DRUG:** encainide
- **DRUG:** moricizine
- **DRUG:** flecainide
- **DRUG:** imipramine

## Key facts

- **NCT ID:** NCT00000504
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1982-09
- **Primary completion:** —
- **Final completion:** 1985-09
- **Target enrollment:** — (—)
- **Last updated:** 2012-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000504, "Cardiac Arrhythmia Pilot Study (CAPS)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00000504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*